Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, United States.
Department of Hematology, School of Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Front Immunol. 2019 Apr 2;10:624. doi: 10.3389/fimmu.2019.00624. eCollection 2019.
Data from both animal models and humans have demonstrated that effector memory T cells (T) and central memory T cells (T) from unprimed donors have decreased ability to induce graft-vs-host disease (GVHD). Allospecific T from primed donors do not mediate GVHD. However, the potential of alloreactive T to induce GVHD is not clear. In this study, we sought to answer this question using a novel GVHD model induced by T cell receptor (TCR) transgenic OT-II T cells. Separated from OT-II mice immunized with OVA protein 8 weeks earlier, the allospecific CD44 T were able to mediate skin graft rejection after transfer to naive mice, yet had dramatically decreased ability to induce GVHD. We also found that these allospecific CD44 T persisted in GVHD target organs for more than 30 days post-transplantation, while the expansion of these cells was dramatically decreased during GVHD, suggesting an anergic or exhausted state. These observations provide insights into how allospecific CD4 T respond to alloantigen during GVHD and underscore the fundamental difference of alloresponses mediated by allospecific T in graft rejection and GVHD settings.
从动物模型和人类身上获得的数据表明,未致敏供体的效应记忆 T 细胞(T)和中央记忆 T 细胞(T)诱导移植物抗宿主病(GVHD)的能力降低。来自致敏供体的同种异体 T 细胞不介导 GVHD。然而,同种反应性 T 细胞诱导 GVHD 的潜力尚不清楚。在这项研究中,我们使用 TCR 转基因 OT-II T 细胞诱导的新型 GVHD 模型来回答这个问题。从 8 周前用 OVA 蛋白免疫的 OT-II 小鼠中分离出的同种异体 CD44 T 细胞在转移至未致敏小鼠后能够介导皮肤移植物排斥,但诱导 GVHD 的能力显著降低。我们还发现,这些同种异体 CD44 T 在移植后超过 30 天仍存在于 GVHD 靶器官中,而这些细胞的扩增在 GVHD 期间显著减少,表明处于无反应或耗竭状态。这些观察结果提供了关于同种异体 CD4 T 在 GVHD 期间如何对同种异体抗原作出反应的见解,并强调了同种异体 T 在移植物排斥和 GVHD 环境中介导的同种反应的根本区别。